Analysts Conflicted on These Financial Names: Gladstone Commercial Corp (NASDAQ: GOOD) and Health Insurance Innovations (NASDAQ: HIIQ)

By Jason Carr

Analysts have been eager to weigh in on the Financial sector with new ratings on Gladstone Commercial Corp (NASDAQ: GOOD) and Health Insurance Innovations (NASDAQ: HIIQ).

Gladstone Commercial Corp (NASDAQ: GOOD)

In a report released today, David Corak from B.Riley FBR reiterated a Hold rating on Gladstone Commercial Corp (NASDAQ: GOOD), with a price target of $19. The company’s shares closed yesterday at $17.28, close to its 52-week low of $17.09.

Corak observed:

“Gladstone put up a solid quarter of results, completing the acquisition of two office assets while executing leases/lease extensions at three of its other assets, improving occupancy 10 bps over 3Q. Core FFO did come in one penny below ours and Street estimates, primarily driven by an increase to operating expenses. It is our understanding that the uptick in opex stemmed from a previous acquisition and should not have a material effect going forward, however we will look for more color on the call. Overall, the company made progress on its strategy to expand into its target markets with strong growth characteristics. However, the stock has traded down 18% YTD along with the net lease REIT sector. Given the stock price, we look for color on the earnings call from management about external growth and financing assumptions. We reiterate our Neutral rating and $19 price target.”

According to TipRanks.com, Corak is ranked 0 out of 5 stars with an average return of -4.5% and a 29.0% success rate. Corak covers the Financial sector, focusing on stocks such as National Storage Affiliates Trust, Preferred Apartment Communities, and NorthStar Realty Europe Corp.

Gladstone Commercial Corp has an analyst consensus of Hold, with a price target consensus of $19.

Health Insurance Innovations (NASDAQ: HIIQ)

B.Riley FBR analyst Randy Binner reiterated a Buy rating on Health Insurance Innovations (NASDAQ: HIIQ) today. The company’s shares closed yesterday at $27.05.

Binner noted:

“After the close on February 14, 2018, Health Insurance Innovations, Inc. (HIIQ) released an 8-K announcing that its Florida third-party administrator (TPA) license request was approved by the Florida Office of Insurance Regulation (FOIR). There was a nominal fine of $140,000, which is less than $0.01/share, after tax, as HIIQ operated as an insurance administrator before receiving the license. Also, unrelated to the Florida decision, the Texas Department of Insurance closed its investigation of HIIQ, with no action taken. Regulatory issues have been debatable points for the stock, and we think these favorable resolutions will be well received by investors. We maintain our Buy rating.”

According to TipRanks.com, Binner is a 5-star analyst with an average return of 15.4% and a 72.3% success rate. Binner covers the Financial sector, focusing on stocks such as American Equity Investment Life, American International Group, and National General Holdings.

Currently, the analyst consensus on Health Insurance Innovations is Strong Buy and the average price target is $38.50, representing a 42.3% upside.

In a report released yesterday, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $38 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.